Literature DB >> 23595992

Examining the role of the HIV-1 reverse transcriptase p51 subunit in positioning and hydrolysis of RNA/DNA hybrids.

Suhman Chung1, Jennifer T Miller, Mikalai Lapkouski, Lan Tian, Wei Yang, Stuart F J Le Grice.   

Abstract

Recent crystallographic analysis of p66/p51 human immunodeficiency virus (HIV) type 1 reverse transcriptase (RT) complexed with a non-polypurine tract RNA/DNA hybrid has illuminated novel and important contacts between structural elements at the C terminus of the noncatalytic p51 subunit and the nucleic acid duplex in the vicinity of the ribonuclease H (RNase H) active site. In particular, a short peptide spanning residues Phe-416-Pro-421 was shown to interact with the DNA strand, cross the minor groove of the helix, and then form Van der Waals contacts with the RNA strand adjacent to the scissile phosphate. At the base of the adjoining α-helix M', Tyr-427 forms a hydrogen bond with Asn-348, the latter of which, when mutated to Ile, is implicated in resistance to both nucleoside and non-nucleoside RT inhibitors. Based on our structural data, we analyzed the role of the p51 C terminus by evaluating selectively mutated p66/p51 heterodimers carrying (i) p51 truncations that encroach on α-M', (ii) alterations that interrupt the Asn-348-Tyr-427 interaction, and (iii) alanine substitutions throughout the region Phe-416-Pro-421. Collectively, our data support the notion that the p51 C terminus makes an important contribution toward hybrid binding and orienting the RNA strand for catalysis at the RNase H active site.

Entities:  

Keywords:  Enzyme Mechanisms; Enzyme Structure; HIV; Protein-Nucleic Acid Interaction; Reverse Transcription

Mesh:

Substances:

Year:  2013        PMID: 23595992      PMCID: PMC3668773          DOI: 10.1074/jbc.M113.465641

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

Authors:  F di Marzo Veronese; T D Copeland; A L DeVico; R Rahman; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  Science       Date:  1986-03-14       Impact factor: 47.728

2.  Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer.

Authors:  J Wang; S J Smerdon; J Jäger; L A Kohlstaedt; P A Rice; J M Friedman; T A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

3.  Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA.

Authors:  S G Sarafianos; K Das; C Tantillo; A D Clark; J Ding; J M Whitcomb; P L Boyer; S H Hughes; E Arnold
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

4.  Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution.

Authors:  J Ding; K Das; C Tantillo; W Zhang; A D Clark; S Jessen; X Lu; Y Hsiou; A Jacobo-Molina; K Andries
Journal:  Structure       Date:  1995-04-15       Impact factor: 5.006

5.  Mutation of amino acids in the connection domain of human immunodeficiency virus type 1 reverse transcriptase that contact the template-primer affects RNase H activity.

Authors:  John G Julias; Mary Jane McWilliams; Stefan G Sarafianos; W Gregory Alvord; Edward Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  Modulation of HIV-1 reverse transcriptase function in "selectively deleted" p66/p51 heterodimers.

Authors:  P S Jacques; B M Wöhrl; K J Howard; S F Le Grice
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

7.  Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.

Authors:  L A Kohlstaedt; J Wang; J M Friedman; P A Rice; T A Steitz
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

8.  Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase.

Authors:  S F Le Grice; T Naas; B Wohlgensinger; O Schatz
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

9.  Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation.

Authors:  S F Le Grice; J Mills; J Mous
Journal:  EMBO J       Date:  1988-08       Impact factor: 11.598

10.  Complexes of HIV-1 RT, NNRTI and RNA/DNA hybrid reveal a structure compatible with RNA degradation.

Authors:  Mikalai Lapkouski; Lan Tian; Jennifer T Miller; Stuart F J Le Grice; Wei Yang
Journal:  Nat Struct Mol Biol       Date:  2013-01-13       Impact factor: 15.369

View more
  12 in total

1.  The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.

Authors:  Guney Boso; Claes Örvell; Nikunj V Somia
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Structural requirements for RNA degradation by HIV-1 reverse transcriptase.

Authors:  Kalyan Das; Stefan G Sarafianos; Eddy Arnold
Journal:  Nat Struct Mol Biol       Date:  2013-12       Impact factor: 15.369

3.  Molecular dynamics study of HIV-1 RT-DNA-nevirapine complexes explains NNRTI inhibition and resistance by connection mutations.

Authors:  R S K Vijayan; Eddy Arnold; Kalyan Das
Journal:  Proteins       Date:  2013-11-22

4.  Structural integrity of the ribonuclease H domain in HIV-1 reverse transcriptase.

Authors:  Ryan L Slack; Justin Spiriti; Jinwoo Ahn; Michael A Parniak; Daniel M Zuckerman; Rieko Ishima
Journal:  Proteins       Date:  2015-07-01

Review 5.  Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

Authors:  Kamalendra Singh; Jacqueline A Flores; Karen A Kirby; Ujjwal Neogi; Anders Sonnerborg; Atsuko Hachiya; Kalyan Das; Eddy Arnold; Carole McArthur; Michael Parniak; Stefan G Sarafianos
Journal:  Viruses       Date:  2014-09-24       Impact factor: 5.048

6.  Effects of HIV-1 reverse transcriptase connection subdomain mutations on polypurine tract removal and initiation of (+)-strand DNA synthesis.

Authors:  Gilberto Betancor; Mar Álvarez; Barbara Marcelli; Cristina Andrés; Miguel A Martínez; Luis Menéndez-Arias
Journal:  Nucleic Acids Res       Date:  2015-02-06       Impact factor: 16.971

7.  A computational study for rational HIV-1 non-nucleoside reverse transcriptase inhibitor selection and the discovery of novel allosteric pockets for inhibitor design.

Authors:  Ron Zhi-Hui Chiang; Samuel Ken-En Gan; Chinh Tran-To Su
Journal:  Biosci Rep       Date:  2018-03-05       Impact factor: 3.840

Review 8.  Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review.

Authors:  Olga Tarasova; Vladimir Poroikov; Alexander Veselovsky
Journal:  Molecules       Date:  2018-05-21       Impact factor: 4.411

9.  Fate of HIV-1 cDNA intermediates during reverse transcription is dictated by transcription initiation site of virus genomic RNA.

Authors:  Takao Masuda; Yoko Sato; Yu-Lun Huang; Satoshi Koi; Tatsuro Takahata; Atsuhiko Hasegawa; Gota Kawai; Mari Kannagi
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

10.  Binding interface and impact on protease cleavage for an RNA aptamer to HIV-1 reverse transcriptase.

Authors:  Phuong D M Nguyen; Jie Zheng; Thomas J Gremminger; Liming Qiu; Dong Zhang; Steve Tuske; Margaret J Lange; Patrick R Griffin; Eddy Arnold; Shi-Jie Chen; Xiaoqin Zou; Xiao Heng; Donald H Burke
Journal:  Nucleic Acids Res       Date:  2020-03-18       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.